Adrian F. Arechiga, Ph.D. - Publications

Affiliations: 
2006 University of California, Irvine, Irvine, CA 
Area:
Molecular Biology, Immunology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A, Buckner JH. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. Journal of Immunology (Baltimore, Md. : 1950). 182: 3343-7. PMID 19265110 DOI: 10.4049/Jimmunol.0713370  0.578
2008 Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA, Morrissette NS, Walsh CM. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 16677-82. PMID 18946037 DOI: 10.1073/Pnas.0808597105  0.688
2007 Arechiga AF, Bell BD, Leverrier S, Weist BM, Porter M, Wu Z, Kanno Y, Ramos SJ, Ong ST, Siegel R, Walsh CM. A Fas-associated death domain protein/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. Journal of Immunology (Baltimore, Md. : 1950). 179: 5291-300. PMID 17911615 DOI: 10.4049/Jimmunol.179.8.5291  0.587
2007 Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 179: 4704-10. PMID 17878369 DOI: 10.4049/Jimmunol.179.7.4704  0.53
2007 Rieck M, Concannon P, Arechiga A, Buckner J, Onengut-Gumuscu S. Decrease in Memory B Cell Frequency and Activation is Associated with PTPN22 1858T Variant in Healthy Subjects Clinical Immunology. 123: S125. DOI: 10.1016/J.Clim.2007.03.535  0.411
2006 Sandu C, Morisawa G, Wegorzewska I, Huang T, Arechiga AF, Hill JM, Kim T, Walsh CM, Werner MH. FADD self-association is required for stable interaction with an activated death receptor. Cell Death and Differentiation. 13: 2052-61. PMID 16710361 DOI: 10.1038/Sj.Cdd.4401966  0.68
2005 Arechiga AF, Bell BD, Solomon JC, Chu IH, Dubois CL, Hall BE, George TC, Coder DM, Walsh CM. Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation. Journal of Immunology (Baltimore, Md. : 1950). 175: 7800-4. PMID 16339514 DOI: 10.4049/Jimmunol.175.12.7800  0.754
2003 Walsh CM, Luhrs KA, Arechiga AF. The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. Journal of Clinical Immunology. 23: 333-53. PMID 14601642 DOI: 10.1023/A:1025313415487  0.687
2003 Ly C, Arechiga AF, Melo JV, Walsh CM, Ong ST. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin. Cancer Research. 63: 5716-22. PMID 14522890  0.652
2003 Beisner DR, Chu IH, Arechiga AF, Hedrick SM, Walsh CM. The requirements for Fas-associated death domain signaling in mature T cell activation and survival. Journal of Immunology (Baltimore, Md. : 1950). 171: 247-56. PMID 12817005 DOI: 10.4049/Jimmunol.171.1.247  0.783
Show low-probability matches.